These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12642039)

  • 1. How a statin might destroy a drug company.
    Lancet; 2003 Mar; 361(9360):793. PubMed ID: 12642039
    [No Abstract]   [Full Text] [Related]  

  • 2. The withdrawal of Baycol (cerivastatin).
    Griffin JP
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):177-80. PubMed ID: 11770168
    [No Abstract]   [Full Text] [Related]  

  • 3. Bayer pulls cerivastatin (Baycol) from market.
    Wooltorton E
    CMAJ; 2001 Sep; 165(5):632. PubMed ID: 11563216
    [No Abstract]   [Full Text] [Related]  

  • 4. Bayer faces potential fine over cholesterol lowering drug.
    Tuffs A
    BMJ; 2001 Aug; 323(7310):415. PubMed ID: 11520825
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerivastatin withdrawn from market.
    Thompson CA
    Am J Health Syst Pharm; 2001 Sep; 58(18):1685. PubMed ID: 11571807
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis and cerivastatin: was it a problem of dose?
    Kalaria D; Wassenaar W
    CMAJ; 2002 Oct; 167(7):737. PubMed ID: 12389822
    [No Abstract]   [Full Text] [Related]  

  • 7. Bayer is forced to release documents over withdrawal of cerivastatin.
    Marwick C
    BMJ; 2003 Mar; 326(7388):518. PubMed ID: 12623898
    [No Abstract]   [Full Text] [Related]  

  • 8. Baycol: take-home messages about medications.
    Harv Heart Lett; 2001 Oct; 12(2):2-3. PubMed ID: 11684487
    [No Abstract]   [Full Text] [Related]  

  • 9. Bayer's response to "potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis".
    Piorkowski JD
    JAMA; 2004 Dec; 292(21):2655-7; discussion 2658-9. PubMed ID: 15572725
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
    Marsà Carretero M; Alos Manrique C; Valles Callol JA
    Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerivastatin and acute kidney failure caused by rhabdomyolysis].
    Bravo JJ; Novoa D; Romero R; Sánchez-Guisande D
    Nefrologia; 2001; 21(5):509. PubMed ID: 11795023
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins and myotoxicity.
    Yan L; Lan F; Wang ZG; Li YP
    Trends Pharmacol Sci; 2003 Mar; 24(3):113-4. PubMed ID: 12628352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
    SantaCruz PL; González A; León ME; Fernández MY
    Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
    [No Abstract]   [Full Text] [Related]  

  • 14. Bayer voluntarily withdraws Baycol.
    AWHONN Lifelines; 2001; 5(5):21. PubMed ID: 11982285
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerivastatin and reports of fatal rhabdomyolysis.
    Staffa JA; Chang J; Green L
    N Engl J Med; 2002 Feb; 346(7):539-40. PubMed ID: 11844864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH; Zakowski LJ; McBride PE
    WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baycol withdrawn from market.
    SoRelle R
    Circulation; 2001 Aug; 104(8):E9015-6. PubMed ID: 11521677
    [No Abstract]   [Full Text] [Related]  

  • 19. Learning from the cerivastatin experience.
    Farmer JA
    Lancet; 2001 Oct; 358(9291):1383-5. PubMed ID: 11705478
    [No Abstract]   [Full Text] [Related]  

  • 20. Statin safety.
    Foxton J
    Nurs Stand; 2001 Sep 19-25; 16(1):20. PubMed ID: 11977679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.